Scientists identify genetic marker for gastric cancer prognosis
Although immunotherapy is seen as a very promising treatment for cancer, currently only 20 to 30 percent of patients respond positively. Being able to identify the people most likely to benefit from the costly therapy is a Holy Grail for oncologists. In the current online edition of JAMA Oncology, scientists at Wake Forest Baptist Medical Center report finding a new […]
Continue reading »